Last updated on June 2019

Safety Tolerability Pharmacokinetics and Antiviral Activity of IONIS-HBVRx in Treatment-Na ve Patients With Chronic HBV Infection


Brief description of study

To examine the safety and tolerability of IONIS-HBVRx administration to treatment-naive patients with chronic hepatitis B virus infection

Detailed Study Description

This study examines the effects of IONIS-HBVRx or placebo (3:1 randomization) administered subcutaneously to treatment-nave patients who are chronically infected with HBV and the effects of subsequent nucleos(t)ide analogue treatment on these patients.

Clinical Study Identifier: NCT02981602

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.